Literature DB >> 22811814

Radiation therapy in the postoperative management of esophageal cancer.

Salma K Jabbour1, Charles R Thomas.   

Abstract

The optimal management of esophageal cancer is complicated since institutional preferences vary, patient characteristics often guide management, and there are data to support multiple approaches for locally advanced esophageal cancer. Although surgery is an important component of therapy, alone it results in unacceptably high rates of local relapse and poor long-term survival rates. Well-studied adjuvant approaches include upfront chemoradiation therapy with or without surgery, periopera-tive chemotherapy, adjuvant radiation or adjuvant chemoradiation. This review article seeks to examine thoroughly the role of postoperative therapeutic options for the management of esophageal cancer, and in so doing, also overviews prospective trials in the neoadjuvant, definitive and perioperative settings. Studies evaluating radiation field design are also discussed.

Entities:  

Keywords:  chemoradiation therapy; esophageal cancer; postoperative; radiation therapy

Year:  2010        PMID: 22811814      PMCID: PMC3397583          DOI: 10.3978/j.issn.2078-6891.2010.013

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  41 in total

1.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

Authors:  John D Urschel; Hari Vasan
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

2.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Authors:  Michael Stahl; Martin Stuschke; Nils Lehmann; Hans-Joachim Meyer; Martin K Walz; Siegfried Seeber; Bodo Klump; Wilfried Budach; Reinhard Teichmann; Marcus Schmitt; Gerd Schmitt; Claus Franke; Hansjochen Wilke
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

3.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

Authors:  Laurent Bedenne; Pierre Michel; Olivier Bouché; Chantal Milan; Christophe Mariette; Thierry Conroy; Denis Pezet; Bernard Roullet; Jean-François Seitz; Jean-Philippe Herr; Bernard Paillot; Patrick Arveux; Franck Bonnetain; Christine Binquet
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

4.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Authors:  Val Gebski; Bryan Burmeister; B Mark Smithers; Kerwyn Foo; John Zalcberg; John Simes
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

Review 5.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

6.  Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research.

Authors:  P Ténière; J M Hay; A Fingerhut; P L Fagniez
Journal:  Surg Gynecol Obstet       Date:  1991-08

7.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

Authors:  Joel Tepper; Mark J Krasna; Donna Niedzwiecki; Donna Hollis; Carolyn E Reed; Richard Goldberg; Krystyna Kiel; Christopher Willett; David Sugarbaker; Robert Mayer
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

8.  Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study.

Authors:  H U Zieren; J M Müller; C A Jacobi; H Pichlmaier; R P Müller; S Staar
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

9.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

Review 10.  Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.

Authors:  Richard A Malthaner; Rebecca Ks Wong; R Bryan Rumble; Lisa Zuraw
Journal:  BMC Med       Date:  2004-09-24       Impact factor: 8.775

View more
  13 in total

1.  Esophageal cancer: Is preoperative chemoradiation the new standard?

Authors:  Prajnan Das
Journal:  J Gastrointest Oncol       Date:  2010-12

2.  Does postoperative radiation therapy benefit patients with esophageal cancer?

Authors:  Lawrence Kleinberg
Journal:  J Gastrointest Oncol       Date:  2010-12

3.  Early enteral infusion of traditional Chinese medicine preparation can effectively promote the recovery of gastrointestinal function after esophageal cancer surgery.

Authors:  Yi Hu; Yun Ma; Jian Wang; Zhi-Hua Zhu
Journal:  J Thorac Dis       Date:  2011-12       Impact factor: 2.895

4.  Beclin 1 expression is associated with the occurrence and development of esophageal squamous cell carcinoma.

Authors:  Hailei Du; Jiamin Che; Minmin Shi; Lianggang Zhu; Jun Biao Hang; Zhongyuan Chen; Hecheng Li
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967

5.  A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma.

Authors:  Yang Ling; Jia Chen; Min Tao; Xiaoyuan Chu; Xizhi Zhang
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

Review 6.  Esophageal cancer management controversies: Radiation oncology point of view.

Authors:  Patricia Tai; Edward Yu
Journal:  World J Gastrointest Oncol       Date:  2014-08-15

Review 7.  Current state of prognostication, therapy and prospective innovations for Barrett's-related esophageal adenocarcinoma: a literature review.

Authors:  Sumeet K Mittal; Joe Abdo; Malika P Adrien; Binyam A Bayu; Jay R Kline; Molly M Sullivan; Devendra K Agrawal
Journal:  J Gastrointest Oncol       Date:  2021-08

8.  Adjuvant radiotherapy in oesophageal cancer with positive circumferential resection margins-recurrence and survival outcomes.

Authors:  Bhamini Vadhwana; Dimitrios Zosimas; Panagis M Lykoudis; Huan Ming Phen; Maria Martinou; Thangadorai Amalesh; David Khoo
Journal:  J Gastrointest Oncol       Date:  2019-06

9.  HtrA1 expression associated with the occurrence and development of esophageal cancer.

Authors:  Youtao Yu; Wenlong Shao; Yi Hu; Jingyan Zhang; Hao Song; Zhi-hua Zhu
Journal:  World J Surg Oncol       Date:  2012-08-30       Impact factor: 2.754

10.  Efficacy of postoperative radiotherapy in esophageal squamous cell carcinoma patients with positive circumferential resection margin.

Authors:  Reiko Otake; Akihiko Okamura; Kotaro Yamashita; Yu Imamura; Jun Kanamori; Ryotaro Kozuki; Keita Takahashi; Tasuku Toihata; Noriko Yamamoto; Takao Asari; Shinji Mine; Masayuki Watanabe
Journal:  Esophagus       Date:  2020-10-27       Impact factor: 4.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.